2026 · 2nd Quarter (Apr 1 - June 30)

AMGEN INC.

Filed by TODD STRATEGY GROUP.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 20, 2026
Income: $80,000.00
Expenses: Not reported
Registrant: TODD STRATEGY GROUP
Client: AMGEN INC.
Filing UUID: 5757b765-dbf6-48fe-b0db-5c4955bbc82a
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Medicare/Medicaid payment reform. Implementation of Inflation Reduction Act of 2022.

HCR · Health Issues

Prescription Drug Pricing Policy. Supply Chain Issues.

TAX · Taxation/Internal Revenue Code

Prescription drug pricing policy.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.